Pharmaceutical firm bags White City for new HQ in Life Sciences Hub
Today (November 28), Stanhope, Mitsui Fudosan and AIMCo have announced that Novartis, a pharmaceutical brand, has become the latest life sciences company to open a new head office in White City Place.
Novartis will be joining fellow life sciences companies, Autolus, and Synthace, in residency at White City Place with further announcements of other companies taking space at White City Place in the immediate pipeline.
Novartis will initially be taking 54,000 sq ft of space in March 2019, with the option to expand further to 65,000 sq ft, and will move in by January 2020.
David Camp, Stanhope’s chief executive, said: “We are delighted that Novartis has chosen WestWorks at White City Place as their new headquarters in the UK.
“The addition of Novartis to WestWorks shows the growth of science and innovation within White City, the best new neighbourhood in London.
“With the transformation of White City Place and the development of Imperial College’s new campus, White City has confirmed itself as the destination of choice for emerging and advanced life sciences companies.”
Underpinned by the Hammersmith and Fulham Industrial Strategy, White City Place encourages collaboration between its tenants and the wider life sciences community.
Other tenants at White City Place include the Yoox Net-a-Porter technology centre; the workspace accelerator for tech businesses and biotech startups; Huckletree West; and scaleups, Attention Seekers and Arts Alliance Media.
The offices at nearby Television Centre are now 100 per cent let with Publicis Media to move in next Spring to occupy 212,000 sq ft across seven floors of 2 Television Centre.
Neighbours at Television Centre include the BBC who have three working studios, ITV Studios who broadcast Daytime TV from Television Centre, BBC Worldwide, 432 residential apartments and the Soho House club, White City House.
Knight Frank and Cushman & Wakefield acted for Stanhope. Novartis were represented by Cushman & Wakefield.